文献速递老年综合评估衰弱、肌少症与跌倒老年慢病共病管理

治疗前肌力与躯体功能对接受综合老年评估的老年癌症患者治疗方案调整的影响

The impact of pre-treatment muscle strength and physical performance on treatment modification in older adults with cancer following comprehensive geriatric assessment.
PubMed 文献 · Age Ageing · 2022-01-01

该回顾性队列研究纳入515例接受癌症治疗前综合老年评估(CGA)的老年患者(平均年龄80.7岁),66.4%存在低肌力和/或低躯体功能,49.5%在CGA后治疗方案被调整。多因素分析显示低握力和/或低SPPB联合可预测治疗调整(OR=1.77,95%CI=1.07-2.90,P=0.025)。

要点

  • 低握力和/或低SPPB联合可预测CGA后治疗调整(OR=1.77,95%CI=1.07-2.90,P=0.025)。
  • 66.4%的老年癌症患者存在低肌力和/或低躯体功能。
  • 49.5%的患者在CGA后治疗方案被调整(降低强度或转为支持治疗)。

核心结论

  • 治疗前低握力和/或低SPPB联合可预测老年癌症患者CGA后的治疗调整,可能有助于治疗决策。

研究设计与样本

  • 回顾性队列研究,纳入515例接受癌症治疗前CGA的老年患者(平均年龄80.7岁),数据来自学术癌症中心前瞻性数据库和病历。

主要发现

  • 66.4%的参与者存在低肌力和/或低躯体功能。
  • 49.5%的参与者在CGA后治疗方案被调整。
  • 多因素分析显示低握力和/或低SPPB联合预测治疗调整(OR=1.77,95%CI=1.07-2.90,P=0.025)。
  • 其他预测因素包括姑息治疗意图、合并症和营养不良。

关键数值与推荐

  • 治疗调整定义为降低治疗强度或从积极治疗转为支持治疗。
  • 低握力和/或低SPPB联合与治疗调整的OR=1.77(95%CI=1.07-2.90,P=0.025)。

临床怎么用

  • 对老年癌症患者,治疗前应评估握力和SPPB,低握力和/或低SPPB联合提示可能需要调整治疗方案。
  • 应针对肌力和躯体功能下降进行管理,以优化患者照护并可能改善治疗结局。

局限性

  • 本研究为回顾性队列研究,数据来自单中心学术癌症中心的前瞻性数据库和病历。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Grip strength (GS) and the short physical performance battery (SPPB) have been shown to predict clinical outcomes in older adults with cancer. However, whether pre-treatment GS and SPPB impact treatment decisions following comprehensive geriatric assessment (CGA) is poorly understood. Our objective was to assess the impact of low GS and/or SPPB on treatment modification to initially proposed treatment plans in older adults with cancer following CGA. METHODS: This was a retrospective cohort study of older adults who had undergone CGA before receiving cancer treatment. Data were retrieved from a prospective database in an academic cancer centre and medical records. Treatment modification following CGA was defined as reduced treatment intensity or transition from active treatment to supportive care. Multivariable logistic regression assessed the impact of pre-treatment GS and SPPB on treatment modification following CGA. RESULTS: In total, 515 older adults (mean age: 80.7y) who had undergone CGA prior to cancer treatment were included. Low muscle strength and/or physical performance was observed in 66.4% of participants. Treatment was modified in 49.5% of the cohort following CGA. Low GS and/or SPPB combined was predictive of treatment modification (OR = 1.77, 95%CI = 1.07-2.90, P = 0.025) in multivariable analysis. Additional predictors of treatment modification included palliative treatment intent, comorbidities and malnutrition. CONCLUSIONS: Low GS and/or SPPB combined prior to cancer treatment predicts treatment modification in older adults with cancer and may be useful in treatment decision-making. Management of poor muscle strength and physical performance should be offered to optimize patient care and potentially improve treatment outcomes.

来源:Age Ageing,查看原文。版权归原作者所有。

引用

  1. Papadopoulos E, Helal AA, Jin R, et al. The impact of pre-treatment muscle strength and physical performance on treatment modification in older adults with cancer following comprehensive geriatric assessment. Age Ageing. 2022. PMID: 35776670. doi:10.1093/ageing/afac152

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。